SZSE:301075 (China)
Â
Class A
Â¥
18.60
(-0.37%)
May 24
Business Description
Tibet Duo Rui Pharmaceutical Co Ltd
ISIN : CNE100004RW5
Share Class Description:
SZSE:301075: Class ACompare
Compare
Traded in other countries / regions
301075.China IPO Date
2021-09-29Description
Duo Rui Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chemical pharmaceutical preparations and their raw materials.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.87 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.37 | |||||
| Debt-to-EBITDA | 11.1 | |||||
| Interest Coverage | 2.9 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 4.14 | |||||
| Beneish M-Score | -2.05 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -19.5 | |||||
| 3-Year EBITDA Growth Rate | -38.2 | |||||
| 3-Year EPS without NRI Growth Rate | -64.4 | |||||
| 3-Year Book Growth Rate | 33.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 23.33 | |||||
| 9-Day RSI | 37.15 | |||||
| 14-Day RSI | 42.65 | |||||
| 6-1 Month Momentum % | -39.59 | |||||
| 12-1 Month Momentum % | -30.01 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.43 | |||||
| Quick Ratio | 5.18 | |||||
| Cash Ratio | 4.08 | |||||
| Days Inventory | 78.94 | |||||
| Days Sales Outstanding | 81.82 | |||||
| Days Payable | 45.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | -6.71 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 62.63 | |||||
| Operating Margin % | 3.21 | |||||
| Net Margin % | 5.6 | |||||
| FCF Margin % | -14.18 | |||||
| ROE % | 2.44 | |||||
| ROA % | 1.82 | |||||
| ROIC % | 1.6 | |||||
| ROC (Joel Greenblatt) % | 9.53 | |||||
| ROCE % | 2.88 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 77.5 | |||||
| PE Ratio without NRI | 76.54 | |||||
| PS Ratio | 4.39 | |||||
| PB Ratio | 1.99 | |||||
| Price-to-Tangible-Book | 2.09 | |||||
| EV-to-EBIT | 50.64 | |||||
| EV-to-EBITDA | 50.64 | |||||
| EV-to-Revenue | 3.75 | |||||
| EV-to-FCF | -28.11 | |||||
| Price-to-Graham-Number | 2.67 | |||||
| Price-to-Net-Current-Asset-Value | 4.72 | |||||
| Price-to-Net-Cash | 10.16 | |||||
| Earnings Yield (Greenblatt) % | 1.97 | |||||
| FCF Yield % | -3.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Tibet Duo Rui Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 334.672 | ||
| EPS (TTM) (Â¥) | 0.24 | ||
| Beta | 0 | ||
| Volatility % | 36.2 | ||
| 14-Day RSI | 42.65 | ||
| 14-Day ATR (Â¥) | 0.90015 | ||
| 20-Day SMA (Â¥) | 19.526 | ||
| 12-1 Month Momentum % | -30.01 | ||
| 52-Week Range (Â¥) | 12.6 - 35.54 | ||
| Shares Outstanding (Mil) | 80 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Tibet Duo Rui Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Tibet Duo Rui Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Tibet Duo Rui Pharmaceutical Co Ltd Frequently Asked Questions
What is Tibet Duo Rui Pharmaceutical Co Ltd(SZSE:301075)'s stock price today?
The current price of SZSE:301075 is ¥18.60. The 52 week high of SZSE:301075 is ¥35.54 and 52 week low is ¥12.60.
When is next earnings date of Tibet Duo Rui Pharmaceutical Co Ltd(SZSE:301075)?
The next earnings date of Tibet Duo Rui Pharmaceutical Co Ltd(SZSE:301075) is .
Does Tibet Duo Rui Pharmaceutical Co Ltd(SZSE:301075) pay dividends? If so, how much?
Tibet Duo Rui Pharmaceutical Co Ltd(SZSE:301075) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers